Ebitda Zmiana Data
Amgen USD 3.66B 713M 2023-12
Arrowhead Research USD -132282000 27.81M 2023-12
AstraZeneca USD 3.43B 412M 2023-09
BioMarin Pharmaceutical USD 55.08M 3.73M 2023-12
Bristol-Myers Squibb USD 4.89B 261M 2023-12
Celldex Therapeutics USD -40472000 8.73M 2023-09
Daiichi Sankyo JPY 65.42B 7.22B 2023-09
Eli Lilly USD 3.84B 1.88B 2023-09
Halozyme Therapeutics USD 121.73M 10.37M 2023-12
Heron Therapeutics USD -24202000 17.46M 2023-09
Ionis Pharmaceuticals USD -2924000 137.16M 2023-12
Ligand Pharmaceuticals USD 5.56M 4.01M 2023-12
Neurocrine Biosciences USD 146.7M 68M 2023-09
Pfizer USD 1.14B 2.05B 2023-12
Regeneron Pharmaceuticals USD 1.32B 196.8M 2023-09
Rigel Pharmaceuticals USD -4173000 798K 2023-09
Ultragenyx Pharmaceutical USD -137906000 4.69M 2023-09
Veracyte USD 2.87M 7.62M 2023-12



Rigel Pharmaceuticals - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2024.